280 related articles for article (PubMed ID: 30952736)
41. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
[TBL] [Abstract][Full Text] [Related]
42. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis.
Sprinzl GM; Galvan O; de Vries A; Ulmer H; Gunkel AR; Lukas P; Thumfart WF
Eur J Cancer; 2001 Nov; 37(16):2003-9. PubMed ID: 11597377
[TBL] [Abstract][Full Text] [Related]
43. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
[TBL] [Abstract][Full Text] [Related]
44. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
[TBL] [Abstract][Full Text] [Related]
45. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
46. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
Makkonen TA; Boström P; Vilja P; Joensuu H
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
[TBL] [Abstract][Full Text] [Related]
47. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
48. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Watanabe T; Ishihara M; Matsuura K; Mizuta K; Itoh Y
Int J Cancer; 2010 Oct; 127(8):1984-90. PubMed ID: 20104529
[TBL] [Abstract][Full Text] [Related]
49. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.
Stokman MA; Spijkervet FK; Burlage FR; Dijkstra PU; Manson WL; de Vries EG; Roodenburg JL
Br J Cancer; 2003 Apr; 88(7):1012-6. PubMed ID: 12671696
[TBL] [Abstract][Full Text] [Related]
50. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
51. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
52. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma.
Jiang C; Wang H; Xia C; Dong Q; Chen E; Qiu Y; Su Y; Xie H; Zeng L; Kuang J; Ao F; Gong X; Li J; Chen T
Cancer; 2019 Apr; 125(7):1081-1090. PubMed ID: 30521105
[TBL] [Abstract][Full Text] [Related]
53. Assessment and prevalence of concomitant chemo-radiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Minhas S; Sajjad A; Chaudhry RM; Zahid H; Shahid A; Kashif M
Turk J Med Sci; 2021 Apr; 51(2):675-684. PubMed ID: 33155791
[TBL] [Abstract][Full Text] [Related]
54. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.
Cerchietti LC; Navigante AH; Bonomi MR; Zaderajko MA; Menéndez PR; Pogany CE; Roth BM
Cancer; 2002 Nov; 95(10):2230-6. PubMed ID: 12412178
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the correlation between side effects to oral mucosa, salivary glands, and general health status with quality of life during intensity-modulated radiotherapy for head and neck cancer.
Oba MK; Innocentini LMAR; Viani G; Ricz HMA; de Carvalho Reis T; Ferrari TC; de Macedo LD
Support Care Cancer; 2021 Jan; 29(1):127-134. PubMed ID: 32318870
[TBL] [Abstract][Full Text] [Related]
56. Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy.
Adamietz IA; Rahn R; Böttcher HD; Schäfer V; Reimer K; Fleischer W
Support Care Cancer; 1998 Jul; 6(4):373-7. PubMed ID: 9695205
[TBL] [Abstract][Full Text] [Related]
57. Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer.
Vesty A; Gear K; Biswas K; Mackenzie BW; Taylor MW; Douglas RG
Support Care Cancer; 2020 Jun; 28(6):2683-2691. PubMed ID: 31650293
[TBL] [Abstract][Full Text] [Related]
58. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
[TBL] [Abstract][Full Text] [Related]
59. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.
Nicolatou-Galitis O; Sarri T; Bowen J; Di Palma M; Kouloulias VE; Niscola P; Riesenbeck D; Stokman M; Tissing W; Yeoh E; Elad S; Lalla RV;
Support Care Cancer; 2013 Nov; 21(11):3179-89. PubMed ID: 23702538
[TBL] [Abstract][Full Text] [Related]
60. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial.
Tsujimoto T; Yamamoto Y; Wasa M; Takenaka Y; Nakahara S; Takagi T; Tsugane M; Hayashi N; Maeda K; Inohara H; Uejima E; Ito T
Oncol Rep; 2015 Jan; 33(1):33-9. PubMed ID: 25351453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
